Arca
Skip to content

Warning Letter to Tecres S.p.A.

Medical Devices. See Tecres S.p.A.'s company page or this site's inspections.

On Aug 20, 2019, FDA's CDRH sent Tecres S.p.A. a warning letter.

  • Letter date: Aug 20, 2019
  • Issued by: CDRH
  • Closeout: —

The Letter

As posted on FDA.gov ↗; cited 21 CFR sections link to their page.

Dear Giovanni Faccioli:

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter (CMS # 459252, dated August 14, 2015). Based on our evaluation, it appears that your firm has addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely, /S/ CAPT Raquel Peat, PhD, MPH, USPHS Director OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

CC: US Agent Cristine Brauer Brauer Device Consultants, LLC. 7 Trail House Court 0Rockville, MD 20850

Record

Recipient
Giovanni Faccioli
FDA site ID (FEI)
3002808402
Cited
—

Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.